-
1
-
-
84877673963
-
Different prognostic factors correlate with Bcl-2 expression among triple negative and non-triple negative breast cancers
-
Abd El-Hafez A, Shawky Mohamed Ael A, Elesawy BH (2013). Different prognostic factors correlate with Bcl-2 expression among triple negative and non-triple negative breast cancers. Asian Pac J Cancer Prev, 14, 1037-41.
-
(2013)
Asian Pac J Cancer Prev
, vol.14
, pp. 1037-1041
-
-
Abd El-Hafez, A.1
Shawky Mohamed Ael, A.2
Elesawy, B.H.3
-
2
-
-
77951941324
-
High expression of BCL-2 predicts favorable outcome in nonsmall cell lung cancer patients with non squamous histology
-
Anagnostou VK, Lowery FJ, Zolota V, et al (2010). High expression of BCL-2 predicts favorable outcome in nonsmall cell lung cancer patients with non squamous histology. BMC Cancer, 10, 186.
-
(2010)
BMC Cancer
, vol.10
, pp. 186
-
-
Anagnostou, V.K.1
Lowery, F.J.2
Zolota, V.3
-
3
-
-
0030928745
-
Absence of prognostic significance of bcl-2 immunopositivity in nonsmall cell lung cancer: analysis of 427 cases
-
Anton RC, Brown RW, Younes M, et al (1997). Absence of prognostic significance of bcl-2 immunopositivity in nonsmall cell lung cancer: analysis of 427 cases. Hum Pathol, 28, 1079-82.
-
(1997)
Hum Pathol
, vol.28
, pp. 1079-1082
-
-
Anton, R.C.1
Brown, R.W.2
Younes, M.3
-
4
-
-
0030940210
-
Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer
-
Apolinario RM, van der Valk P, de Jong JS, et al (1997). Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer. J Clin Oncol, 15, 2456-66.
-
(1997)
J Clin Oncol
, vol.15
, pp. 2456-2466
-
-
Apolinario, R.M.1
van der Valk, P.2
de Jong, J.S.3
-
5
-
-
77955008772
-
Fixed-effect versus random-effects models.
-
introduction to meta-analysis, John Wiley & Sons, Ltd.
-
Borenstein M HL, Higgins JPT, Rothstein HR 2009. Fixed-effect versus random-effects models. introduction to meta-analysis, John Wiley & Sons, Ltd.
-
(2009)
-
-
Borenstein, M.H.L.1
Higgins, J.P.T.2
Rothstein, H.R.3
-
6
-
-
31344474845
-
Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood
-
Bremnes RM, Camps C, Sirera R (2006). Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Lung Cancer, 51, 143-58.
-
(2006)
Lung Cancer
, vol.51
, pp. 143-158
-
-
Bremnes, R.M.1
Camps, C.2
Sirera, R.3
-
7
-
-
0034522069
-
Useful prognostic panel markers to express the biological tumor status in resected lung adenocarcinomas
-
Carvalho PE, Antonangelo L, Bernardi FD, et al (2000). Useful prognostic panel markers to express the biological tumor status in resected lung adenocarcinomas. Jpn J Clin Oncol, 30, 478-86.
-
(2000)
Jpn J Clin Oncol
, vol.30
, pp. 478-486
-
-
Carvalho, P.E.1
Antonangelo, L.2
Bernardi, F.D.3
-
8
-
-
75949105922
-
The BCL-2 family reunion
-
Chipuk JE, Moldoveanu T, Llambi F, et al (2010). The BCL-2 family reunion. Mol Cell, 37, 299-310.
-
(2010)
Mol Cell
, vol.37
, pp. 299-310
-
-
Chipuk, J.E.1
Moldoveanu, T.2
Llambi, F.3
-
9
-
-
70349376330
-
Molecular predictive and prognostic markers in non-small-cell lung cancer
-
Coate LE, John T, Tsao MS, et al (2009). Molecular predictive and prognostic markers in non-small-cell lung cancer. Lancet Oncol, 10, 1001-10.
-
(2009)
Lancet Oncol
, vol.10
, pp. 1001-1010
-
-
Coate, L.E.1
John, T.2
Tsao, M.S.3
-
10
-
-
33846102093
-
Lung cancer: diagnosis and management
-
Collins LG, Haines C, Perkel R, et al (2007). Lung cancer: diagnosis and management. Am Fam Physician, 75, 56-63.
-
(2007)
Am Fam Physician
, vol.75
, pp. 56-63
-
-
Collins, L.G.1
Haines, C.2
Perkel, R.3
-
11
-
-
0035157618
-
Bcl-2 is an independent prognostic factor and adds to a biological model for predicting outcome in operable non-small cell lung cancer
-
Cox G, Louise Jones J, Andi A, et al (2001). Bcl-2 is an independent prognostic factor and adds to a biological model for predicting outcome in operable non-small cell lung cancer. Lung Cancer, 34, 417-26.
-
(2001)
Lung Cancer
, vol.34
, pp. 417-426
-
-
Cox, G.1
Louise Jones, J.2
Andi, A.3
-
12
-
-
0033845784
-
Does immunointensity account for the differences in prognostic significance of Bcl- 2 expression in non-small cell lung cancer?
-
Cox G, Walker RA, Muller S, et al (2000). Does immunointensity account for the differences in prognostic significance of Bcl- 2 expression in non-small cell lung cancer? Pathol Oncol Res, 6, 87-92.
-
(2000)
Pathol Oncol Res
, vol.6
, pp. 87-92
-
-
Cox, G.1
Walker, R.A.2
Muller, S.3
-
13
-
-
0032959632
-
A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers
-
D'Amico TA, Massey M, Herndon JE, 2nd, et al (1999). A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers. J Thorac Cardiovasc Surg, 117, 736-43.
-
(1999)
J Thorac Cardiovasc Surg
, vol.117
, pp. 736-743
-
-
D'Amico, T.A.1
Massey, M.2
Herndon, J.E.3
-
14
-
-
80455129249
-
Lung cancer: epidemiology, etiology, and prevention
-
Dela Cruz CS, Tanoue LT, Matthay RA (2011). Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med, 32, 605-44.
-
(2011)
Clin Chest Med
, vol.32
, pp. 605-644
-
-
Dela Cruz, C.S.1
Tanoue, L.T.2
Matthay, R.A.3
-
15
-
-
0032924709
-
Bcl-2 expression in non-small cell lung cancers: higher frequency of expression in squamous cell carcinomas with earlier pT status
-
Dosaka-Akita H, Katabami M, Hommura H, et al (1999). Bcl-2 expression in non-small cell lung cancers: higher frequency of expression in squamous cell carcinomas with earlier pT status. Oncology, 56, 259-64.
-
(1999)
Oncology
, vol.56
, pp. 259-264
-
-
Dosaka-Akita, H.1
Katabami, M.2
Hommura, H.3
-
16
-
-
0343471474
-
Language bias in randomised controlled trials published in English and German
-
Egger M, Zellweger-Zahner T, Schneider M, et al (1997). Language bias in randomised controlled trials published in English and German. Lancet, 350, 326-9.
-
(1997)
Lancet
, vol.350
, pp. 326-329
-
-
Egger, M.1
Zellweger-Zahner, T.2
Schneider, M.3
-
17
-
-
33646012979
-
Expression and prognostic implications of apoptosis-related proteins in locally unresectable non-small cell lung cancers
-
Fokkema E, Timens W, de Vries EG, et al (2006). Expression and prognostic implications of apoptosis-related proteins in locally unresectable non-small cell lung cancers. Lung Cancer, 52, 241-7.
-
(2006)
Lung Cancer
, vol.52
, pp. 241-247
-
-
Fokkema, E.1
Timens, W.2
de Vries, E.G.3
-
18
-
-
0032055269
-
Bcl2 and p53 regulate vascular endothelial growth factor (VEGF)- mediated angiogenesis in non-small cell lung carcinoma
-
Fontanini G, Boldrini L, Vignati S, et al (1998). Bcl2 and p53 regulate vascular endothelial growth factor (VEGF)- mediated angiogenesis in non-small cell lung carcinoma. Eur J Cancer, 34, 718-23.
-
(1998)
Eur J Cancer
, vol.34
, pp. 718-723
-
-
Fontanini, G.1
Boldrini, L.2
Vignati, S.3
-
19
-
-
0029035891
-
Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-smallcell lung cancer
-
Fontanini G, Vignati S, Bigini D, et al (1995). Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-smallcell lung cancer. Br J Cancer, 71, 1003-7.
-
(1995)
Br J Cancer
, vol.71
, pp. 1003-1007
-
-
Fontanini, G.1
Vignati, S.2
Bigini, D.3
-
20
-
-
0029891577
-
Recurrence and death in non-small cell lung carcinomas: a prognostic model using pathological parameters, microvessel count, and gene protein products
-
Fontanini G, Vignati S, Bigini D, et al (1996). Recurrence and death in non-small cell lung carcinomas: a prognostic model using pathological parameters, microvessel count, and gene protein products. Clin Cancer Res, 2, 1067-75.
-
(1996)
Clin Cancer Res
, vol.2
, pp. 1067-1075
-
-
Fontanini, G.1
Vignati, S.2
Bigini, D.3
-
21
-
-
84860724888
-
Influence of survivin and Bcl-2 expression on the biological behavior of non-small cell lung cancer
-
Gao Q, Yang S, Kang MQ (2012). Influence of survivin and Bcl-2 expression on the biological behavior of non-small cell lung cancer. Mol Med Rep, 5, 1409-14.
-
(2012)
Mol Med Rep
, vol.5
, pp. 1409-1414
-
-
Gao, Q.1
Yang, S.2
Kang, M.Q.3
-
22
-
-
0030985194
-
Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma
-
Gascoyne RD, Adomat SA, Krajewski S, et al (1997). Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood, 90, 244-51.
-
(1997)
Blood
, vol.90
, pp. 244-251
-
-
Gascoyne, R.D.1
Adomat, S.A.2
Krajewski, S.3
-
23
-
-
77953174764
-
Prognostic significance of mucin and p53 expression in stage IB non-small cell lung cancer: a laboratory companion study to CALGB 9633
-
Graziano SL, Gu L, Wang X, et al (2010). Prognostic significance of mucin and p53 expression in stage IB non-small cell lung cancer: a laboratory companion study to CALGB 9633. J Thorac Oncol, 5, 810-7.
-
(2010)
J Thorac Oncol
, vol.5
, pp. 810-817
-
-
Graziano, S.L.1
Gu, L.2
Wang, X.3
-
24
-
-
77956191770
-
The prognostic role of Bcl-2 mRNA expression in curatively resected non-small cell lung cancer (NSCLC)
-
Grimminger PP, Schneider PM, Metzger R, et al (2010). The prognostic role of Bcl-2 mRNA expression in curatively resected non-small cell lung cancer (NSCLC). Lung Cancer, 70, 82-7.
-
(2010)
Lung Cancer
, vol.70
, pp. 82-87
-
-
Grimminger, P.P.1
Schneider, P.M.2
Metzger, R.3
-
25
-
-
0038579659
-
Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers
-
Grossi F, Loprevite M, Chiaramondia M, et al (2003). Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers. Eur J Cancer, 39, 1242-50.
-
(2003)
Eur J Cancer
, vol.39
, pp. 1242-1250
-
-
Grossi, F.1
Loprevite, M.2
Chiaramondia, M.3
-
26
-
-
0036151569
-
Prognostic value of immunohistochemical expressions of p53, HER-2/ neu, and bcl-2 in stage I non-small-cell lung cancer
-
Han H, Landreneau RJ, Santucci TS, et al (2002). Prognostic value of immunohistochemical expressions of p53, HER-2/ neu, and bcl-2 in stage I non-small-cell lung cancer. Hum Pathol, 33, 105-10.
-
(2002)
Hum Pathol
, vol.33
, pp. 105-110
-
-
Han, H.1
Landreneau, R.J.2
Santucci, T.S.3
-
27
-
-
0035985813
-
Immunohistochemical demonstration of apoptosis-regulated proteins, Bcl-2 and Bax, in resected non-small-cell lung cancers
-
Hanaoka T, Nakayama J, Haniuda M, et al (2002). Immunohistochemical demonstration of apoptosis-regulated proteins, Bcl-2 and Bax, in resected non-small-cell lung cancers. Int J Clin Oncol, 7, 152-8.
-
(2002)
Int J Clin Oncol
, vol.7
, pp. 152-158
-
-
Hanaoka, T.1
Nakayama, J.2
Haniuda, M.3
-
28
-
-
84875192135
-
Multiple functions of BCL-2 family proteins.
-
Cold Spring Harb Perspect Biol
-
Hardwick JM, Soane L (2013). Multiple functions of BCL-2 family proteins. Cold Spring Harb Perspect Biol, 5.
-
(2013)
, pp. 5
-
-
Hardwick, J.M.1
Soane, L.2
-
29
-
-
0031049786
-
bcl-2 oncoprotein in surgically resected non-small cell lung cancer: possibly favorable prognostic factor in association with low incidence of distant metastasis
-
Higashiyama M, Doi O, Kodama K, et al (1997). bcl-2 oncoprotein in surgically resected non-small cell lung cancer: possibly favorable prognostic factor in association with low incidence of distant metastasis. J Surg Oncol, 64, 48-54.
-
(1997)
J Surg Oncol
, vol.64
, pp. 48-54
-
-
Higashiyama, M.1
Doi, O.2
Kodama, K.3
-
30
-
-
0025204548
-
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
-
Hockenbery D, Nunez G, Milliman C, et al (1990). Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature, 348, 334-6.
-
(1990)
Nature
, vol.348
, pp. 334-336
-
-
Hockenbery, D.1
Nunez, G.2
Milliman, C.3
-
31
-
-
0032886796
-
Overexpression of bax associated with mutations in the loop-sheet-helix motif of p53
-
Huang C, Kohno N, Inufusa H, et al (1999). Overexpression of bax associated with mutations in the loop-sheet-helix motif of p53. Am J Pathol, 155, 955-65.
-
(1999)
Am J Pathol
, vol.155
, pp. 955-965
-
-
Huang, C.1
Kohno, N.2
Inufusa, H.3
-
32
-
-
0038340641
-
Expression of bcl-2 protein is associated with shorter survival in nonsmall cell lung carcinoma
-
Huang CI, Neuberg D, Johnson BE, et al (2003). Expression of bcl-2 protein is associated with shorter survival in nonsmall cell lung carcinoma. Cancer, 98, 135-43.
-
(2003)
Cancer
, vol.98
, pp. 135-143
-
-
Huang, C.I.1
Neuberg, D.2
Johnson, B.E.3
-
33
-
-
0035341725
-
Apoptosis and bcl- 2 expression as predictors of survival in radiation-treated non-small-cell lung cancer
-
Hwang JH, Lim SC, Kim YC, et al (2001). Apoptosis and bcl- 2 expression as predictors of survival in radiation-treated non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 50, 13-8.
-
(2001)
Int J Radiat Oncol Biol Phys
, vol.50
, pp. 13-18
-
-
Hwang, J.H.1
Lim, S.C.2
Kim, Y.C.3
-
34
-
-
0030761399
-
The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction
-
Ishida H, Irie K, Itoh T, et al (1997). The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction. Cancer, 80, 1034-45.
-
(1997)
Cancer
, vol.80
, pp. 1034-1045
-
-
Ishida, H.1
Irie, K.2
Itoh, T.3
-
35
-
-
79952232216
-
Global cancer statistics
-
Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
-
36
-
-
84879488639
-
Autophagy and Bcl-2/BNIP3 death regulatory pathway in non-small cell lung carcinomas
-
Karpathiou G, Sivridis E, Koukourakis M, et al (2013). Autophagy and Bcl-2/BNIP3 death regulatory pathway in non-small cell lung carcinomas. APMIS, 121, 592-604.
-
(2013)
APMIS
, vol.121
, pp. 592-604
-
-
Karpathiou, G.1
Sivridis, E.2
Koukourakis, M.3
-
37
-
-
0032430664
-
The interactive effect of Ras, HER2, P53 and Bcl-2 expression in predicting the survival of non-small cell lung cancer patients
-
Kim YC, Park KO, Kern JA, et al (1998). The interactive effect of Ras, HER2, P53 and Bcl-2 expression in predicting the survival of non-small cell lung cancer patients. Lung Cancer, 22, 181-90.
-
(1998)
Lung Cancer
, vol.22
, pp. 181-190
-
-
Kim, Y.C.1
Park, K.O.2
Kern, J.A.3
-
38
-
-
84887600340
-
Prognostic significance of basic laboratory methods in non- small-celllung cancer
-
Kaya V, Yildirim M, Demirpence O, et al (2013). Prognostic significance of basic laboratory methods in non- small-celllung cancer. Asian Pac J Cancer Prev, 14, 5473-6.
-
(2013)
Asian Pac J Cancer Prev
, vol.14
, pp. 5473-5476
-
-
Kaya, V.1
Yildirim, M.2
Demirpence, O.3
-
39
-
-
1442286330
-
The role of Bcl-2 family members in tumorigenesis
-
Kirkin V, Joos S, Zornig M (2004). The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta, 1644, 229-49.
-
(2004)
Biochim Biophys Acta
, vol.1644
, pp. 229-249
-
-
Kirkin, V.1
Joos, S.2
Zornig, M.3
-
40
-
-
84875226091
-
Synergistic effect of Bcl-2 and cyclin A2 on adverse recurrence-free survival in stage I non-small cell lung cancer
-
Ko E, Kim Y, Cho EY, et al (2013). Synergistic effect of Bcl-2 and cyclin A2 on adverse recurrence-free survival in stage I non-small cell lung cancer. Ann Surg Oncol, 20, 1005-12.
-
(2013)
Ann Surg Oncol
, vol.20
, pp. 1005-1012
-
-
Ko, E.1
Kim, Y.2
Cho, E.Y.3
-
41
-
-
0031471135
-
Potential role of bcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer
-
Koukourakis MI, Giatromanolaki A, O'Byrne KJ, et al (1997). Potential role of bcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer. Int J Cancer, 74, 565-70.
-
(1997)
Int J Cancer
, vol.74
, pp. 565-570
-
-
Koukourakis, M.I.1
Giatromanolaki, A.2
O'Byrne, K.J.3
-
42
-
-
0030916669
-
The proto-oncogene Bcl-2 and its role in regulating apoptosis
-
Kroemer G (1997). The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med, 3, 614-20.
-
(1997)
Nat Med
, vol.3
, pp. 614-620
-
-
Kroemer, G.1
-
44
-
-
20244388951
-
Molecular pathologic substaging in 244 stage I non-smallcell lung cancer patients: clinical implications
-
Kwiatkowski DJ, Harpole DH Jr., Godleski J, et al (1998). Molecular pathologic substaging in 244 stage I non-smallcell lung cancer patients: clinical implications. J Clin Oncol, 16, 2468-77.
-
(1998)
J Clin Oncol
, vol.16
, pp. 2468-2477
-
-
Kwiatkowski, D.J.1
Harpole, D.H.2
Godleski, J.3
-
45
-
-
0036780925
-
Prognostic evaluation of the expression of p53 and bcl-2 oncoproteins in patients with surgically resected non-small cell lung cancer
-
Lai RS, Wang JS, Hsu HK, et al (2002). Prognostic evaluation of the expression of p53 and bcl-2 oncoproteins in patients with surgically resected non-small cell lung cancer. Jpn J Clin Oncol, 32, 393-7.
-
(2002)
Jpn J Clin Oncol
, vol.32
, pp. 393-397
-
-
Lai, R.S.1
Wang, J.S.2
Hsu, H.K.3
-
46
-
-
0035019451
-
Prognostic significance of p53 and bcl-2 abnormalities in operable nonsmall cell lung cancer
-
Laudanski J, Niklinska W, Burzykowski T, et al (2001). Prognostic significance of p53 and bcl-2 abnormalities in operable nonsmall cell lung cancer. Eur Respir J, 17, 660-6.
-
(2001)
Eur Respir J
, vol.17
, pp. 660-666
-
-
Laudanski, J.1
Niklinska, W.2
Burzykowski, T.3
-
47
-
-
67651240812
-
Expression of excision repair cross-complementation group 1 protein predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based doublet chemotherapy
-
Lee HW, Choi YW, Han JH, et al (2009). Expression of excision repair cross-complementation group 1 protein predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based doublet chemotherapy. Lung Cancer, 65, 377-82.
-
(2009)
Lung Cancer
, vol.65
, pp. 377-382
-
-
Lee, H.W.1
Choi, Y.W.2
Han, J.H.3
-
48
-
-
55449099990
-
Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer
-
Liu H, Zhang T, Li X, et al (2008). Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer. Cancer Sci, 99, 2185-92.
-
(2008)
Cancer Sci
, vol.99
, pp. 2185-2192
-
-
Liu, H.1
Zhang, T.2
Li, X.3
-
49
-
-
48249087719
-
Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.
-
Ludovini V, Pistola L, Gregorc V, et al (2008). Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors. Tumori, 94, 398-405.
-
(2008)
Tumori
, vol.94
, pp. 398-405
-
-
Ludovini, V.1
Pistola, L.2
Gregorc, V.3
-
50
-
-
75749142311
-
Expression of ERCC1, Bcl-2, MT and their clinical significance in advanced non-small-cell lung cancer treated with cisplatinbased chemotherapy
-
Ma HS H, Huang F, Li J, Cao X, Jiang W (2009). Expression of ERCC1, Bcl-2, MT and their clinical significance in advanced non-small-cell lung cancer treated with cisplatinbased chemotherapy. Latin Am J Pharmacy, 28, 827-34.
-
(2009)
Latin Am J Pharmacy
, vol.28
, pp. 827-834
-
-
Ma, H.S.H.1
Huang, F.2
Li, J.3
Cao, X.4
Jiang, W.5
-
51
-
-
19944430434
-
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis
-
Mascaux C, Iannino N, Martin B, et al (2005). The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer, 92, 131-9.
-
(2005)
Br J Cancer
, vol.92
, pp. 131-139
-
-
Mascaux, C.1
Iannino, N.2
Martin, B.3
-
52
-
-
0002092338
-
Prognostic markers in resected stage I and II non small-cell lung cancer: an analysis of 260 patients with 5 year follow-up
-
Mehdi SA, Tatum AH, Newman NB, et al (1999). Prognostic markers in resected stage I and II non small-cell lung cancer: an analysis of 260 patients with 5 year follow-up. Clin Lung Cancer, 1, 59-67.
-
(1999)
Clin Lung Cancer
, vol.1
, pp. 59-67
-
-
Mehdi, S.A.1
Tatum, A.H.2
Newman, N.B.3
-
53
-
-
0033765491
-
Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis
-
Mitsudomi T, Hamajima N, Ogawa M, et al (2000). Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis. Clin Cancer Res, 6, 4055-63.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 4055-4063
-
-
Mitsudomi, T.1
Hamajima, N.2
Ogawa, M.3
-
54
-
-
68049122102
-
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
-
Moher D, Liberati A, Tetzlaff J, et al (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med, 6, 1000097.
-
(2009)
PLoS Med
, vol.6
, pp. 1000097
-
-
Moher, D.1
Liberati, A.2
Tetzlaff, J.3
-
55
-
-
0034100054
-
Predictive survival markers in patients with surgically resected non-small cell lung carcinoma
-
Moldvay J, Scheid P, Wild P, et al (2000). Predictive survival markers in patients with surgically resected non-small cell lung carcinoma. Clin Cancer Res, 6, 1125-34.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 1125-1134
-
-
Moldvay, J.1
Scheid, P.2
Wild, P.3
-
56
-
-
0033843716
-
Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and bcl-2
-
Nguyen VN, Mirejovsky P, Mirejovsky T, et al (2000). Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and bcl-2. Acta Histochem, 102, 323-38.
-
(2000)
Acta Histochem
, vol.102
, pp. 323-338
-
-
Nguyen, V.N.1
Mirejovsky, P.2
Mirejovsky, T.3
-
57
-
-
0030057349
-
Apoptosis occurs independently of bcl-2 and p53 over-expression in non-small cell lung carcinoma
-
O'Neill AJ, Staunton MJ, Gaffney EF (1996). Apoptosis occurs independently of bcl-2 and p53 over-expression in non-small cell lung carcinoma. Histopathology, 29, 45-50.
-
(1996)
Histopathology
, vol.29
, pp. 45-50
-
-
O'Neill, A.J.1
Staunton, M.J.2
Gaffney, E.F.3
-
58
-
-
0029940427
-
bcl-2 and p53 protein expression in non-small cell lung cancers: correlation with survival time
-
Ohsaki Y, Toyoshima E, Fujiuchi S, et al (1996). bcl-2 and p53 protein expression in non-small cell lung cancers: correlation with survival time. Clin Cancer Res, 2, 915-20.
-
(1996)
Clin Cancer Res
, vol.2
, pp. 915-920
-
-
Ohsaki, Y.1
Toyoshima, E.2
Fujiuchi, S.3
-
59
-
-
0032583387
-
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints
-
Parmar MK, Torri V, Stewart L (1998). Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med, 17, 2815-34.
-
(1998)
Stat Med
, vol.17
, pp. 2815-2834
-
-
Parmar, M.K.1
Torri, V.2
Stewart, L.3
-
60
-
-
17444442088
-
Immunocytochemical markers in stage I lung cancer: relevance to prognosis
-
Pastorino U, Andreola S, Tagliabue E, et al (1997). Immunocytochemical markers in stage I lung cancer: relevance to prognosis. J Clin Oncol, 15, 2858-65.
-
(1997)
J Clin Oncol
, vol.15
, pp. 2858-2865
-
-
Pastorino, U.1
Andreola, S.2
Tagliabue, E.3
-
61
-
-
0027186201
-
bcl-2 protein in nonsmall- cell lung carcinoma
-
Pezzella F, Turley H, Kuzu I, et al (1993). bcl-2 protein in nonsmall- cell lung carcinoma. N Engl J Med, 329, 690-4.
-
(1993)
N Engl J Med
, vol.329
, pp. 690-694
-
-
Pezzella, F.1
Turley, H.2
Kuzu, I.3
-
62
-
-
0036097789
-
Bcl-2 expression inhibits liver carcinogenesis and delays the development of proliferating foci
-
Pierce RH, Vail ME, Ralph L, et al (2002). Bcl-2 expression inhibits liver carcinogenesis and delays the development of proliferating foci. Am J Pathol, 160, 1555-60.
-
(2002)
Am J Pathol
, vol.160
, pp. 1555-1560
-
-
Pierce, R.H.1
Vail, M.E.2
Ralph, L.3
-
63
-
-
84855311144
-
EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study
-
Pirker R, Pereira JR, von Pawel J, et al (2012). EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study. Lancet Oncol, 13, 33-42.
-
(2012)
Lancet Oncol
, vol.13
, pp. 33-42
-
-
Pirker, R.1
Pereira, J.R.2
von Pawel, J.3
-
64
-
-
0037790894
-
Risk of recurrence in patients with surgically resected stage I non-small cell lung carcinoma: histopathologic and immunohistochemical analysis
-
Poleri C, Morero JL, Nieva B, et al (2003). Risk of recurrence in patients with surgically resected stage I non-small cell lung carcinoma: histopathologic and immunohistochemical analysis. Chest, 123, 1858-67.
-
(2003)
Chest
, vol.123
, pp. 1858-1867
-
-
Poleri, C.1
Morero, J.L.2
Nieva, B.3
-
65
-
-
67649396222
-
BCL-2 expression is prognostic for improved survival in non-small cell lung cancer
-
Renouf DJ, Wood-Baker R, Ionescu DN, et al (2009). BCL-2 expression is prognostic for improved survival in non-small cell lung cancer. J Thorac Oncol, 4, 486-91.
-
(2009)
J Thorac Oncol
, vol.4
, pp. 486-491
-
-
Renouf, D.J.1
Wood-Baker, R.2
Ionescu, D.N.3
-
66
-
-
0036838176
-
Blood vessel invasion in resected non small cell lung carcinomas is predictive of metastatic occurrence
-
Rigau V, Molina TJ, Chaffaud C, et al (2002). Blood vessel invasion in resected non small cell lung carcinomas is predictive of metastatic occurrence. Lung Cancer, 38, 169-76.
-
(2002)
Lung Cancer
, vol.38
, pp. 169-176
-
-
Rigau, V.1
Molina, T.J.2
Chaffaud, C.3
-
67
-
-
0028792644
-
Expression of bcl-2 protein in stage T1N0M0 non-small cell lung carcinoma
-
Ritter JH, Dresler CM, Wick MR (1995). Expression of bcl-2 protein in stage T1N0M0 non-small cell lung carcinoma. Hum Pathol, 26, 1227-32.
-
(1995)
Hum Pathol
, vol.26
, pp. 1227-1232
-
-
Ritter, J.H.1
Dresler, C.M.2
Wick, M.R.3
-
68
-
-
42549088992
-
BRCA1: a novel prognostic factor in resected non-small-cell lung cancer
-
Rosell R, Skrzypski M, Jassem E, et al (2007). BRCA1: a novel prognostic factor in resected non-small-cell lung cancer. PLoS One, 2, 1129.
-
(2007)
PLoS One
, vol.2
, pp. 1129
-
-
Rosell, R.1
Skrzypski, M.2
Jassem, E.3
-
69
-
-
33847606952
-
Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews
-
Shea BJ, Grimshaw JM, Wells GA, et al (2007). Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol, 7, 10.
-
(2007)
BMC Med Res Methodol
, vol.7
, pp. 10
-
-
Shea, B.J.1
Grimshaw, J.M.2
Wells, G.A.3
-
70
-
-
79953806752
-
Prognostic and predictive values of pERK1/2 and pAkt-1 expression in non-small cell lung cancer patients treated with adjuvant chemotherapy
-
Shi Y, Chen L, Li J, et al (2011). Prognostic and predictive values of pERK1/2 and pAkt-1 expression in non-small cell lung cancer patients treated with adjuvant chemotherapy. Tumour Biol, 32, 381-90.
-
(2011)
Tumour Biol
, vol.32
, pp. 381-390
-
-
Shi, Y.1
Chen, L.2
Li, J.3
-
71
-
-
3242726111
-
Bcl-2 protein expression correlates with better prognosis in patients with advanced non-small cell lung cancer
-
Shibata Y, Hidaka S, Tagawa Y, et al (2004). Bcl-2 protein expression correlates with better prognosis in patients with advanced non-small cell lung cancer. Anticancer Res, 24, 1925-8.
-
(2004)
Anticancer Res
, vol.24
, pp. 1925-1928
-
-
Shibata, Y.1
Hidaka, S.2
Tagawa, Y.3
-
72
-
-
71649101232
-
HER2 and tau expression as potential markers for response and survival to first line taxane plus cisplatin therapy in non-small cell lung cancer
-
Shim BY, Kim CH, Ahn MI, et al (2009). HER2 and tau expression as potential markers for response and survival to first line taxane plus cisplatin therapy in non-small cell lung cancer. Asian Pac J Clin Oncol, 5, 232-41.
-
(2009)
Asian Pac J Clin Oncol
, vol.5
, pp. 232-241
-
-
Shim, B.Y.1
Kim, C.H.2
Ahn, M.I.3
-
73
-
-
3042816190
-
Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways
-
Swinson DE, Jones JL, Cox G, et al (2004). Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways. Int J Cancer, 111, 43-50.
-
(2004)
Int J Cancer
, vol.111
, pp. 43-50
-
-
Swinson, D.E.1
Jones, J.L.2
Cox, G.3
-
74
-
-
0036755102
-
Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables
-
Swinson DE, Jones JL, Richardson D, et al (2002). Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables. Lung Cancer, 37, 235-40.
-
(2002)
Lung Cancer
, vol.37
, pp. 235-240
-
-
Swinson, D.E.1
Jones, J.L.2
Richardson, D.3
-
75
-
-
34547450763
-
Practical methods for incorporating summary time-to-event data into metaanalysis
-
Tierney JF, Stewart LA, Ghersi D, et al (2007). Practical methods for incorporating summary time-to-event data into metaanalysis. Trials, 8, 16.
-
(2007)
Trials
, vol.8
, pp. 16
-
-
Tierney, J.F.1
Stewart, L.A.2
Ghersi, D.3
-
76
-
-
0141885988
-
Prognostic significance of bcl-2 expression in resected pN2 non-small cell lung cancer
-
Tomita M, Matsuzaki Y, Edagawa M, et al (2003). Prognostic significance of bcl-2 expression in resected pN2 non-small cell lung cancer. Eur J Surg Oncol, 29, 654-7.
-
(2003)
Eur J Surg Oncol
, vol.29
, pp. 654-657
-
-
Tomita, M.1
Matsuzaki, Y.2
Edagawa, M.3
-
77
-
-
13644257725
-
The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Online].
-
Wells GA SB OCD, Peterson J, Welch V, Losos M, Tugwell P (2000). The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Online]. Available: http://www.ohri.ca/programs/clinical_ epidemiology/oxford.asp.
-
(2000)
-
-
Wells, G.A.S.B.O.C.D.1
Peterson, J.2
Welch, V.3
Losos, M.4
Tugwell, P.5
-
78
-
-
0037202566
-
Aggregate data meta-analysis with time-to-event outcomes
-
Williamson PR, Smith CT, Hutton JL, et al (2002). Aggregate data meta-analysis with time-to-event outcomes. Stat Med, 21, 3337-51.
-
(2002)
Stat Med
, vol.21
, pp. 3337-3351
-
-
Williamson, P.R.1
Smith, C.T.2
Hutton, J.L.3
-
79
-
-
33744508879
-
Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis
-
Yaren A, Oztop I, Kargi A, et al (2006). Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis. Int J Clin Pract, 60, 675-82.
-
(2006)
Int J Clin Pract
, vol.60
, pp. 675-682
-
-
Yaren, A.1
Oztop, I.2
Kargi, A.3
-
80
-
-
34248536268
-
Immunohistochemical analysis of non-small cell lung cancer: correlation with clinical parameters and prognosis
-
Yoo J, Jung JH, Lee MA, et al (2007). Immunohistochemical analysis of non-small cell lung cancer: correlation with clinical parameters and prognosis. J Korean Med Sci, 22, 318-25.
-
(2007)
J Korean Med Sci
, vol.22
, pp. 318-325
-
-
Yoo, J.1
Jung, J.H.2
Lee, M.A.3
-
81
-
-
84880314456
-
Effect of Bcl-2 on apoptosis and transcription factor NF-kappaB activation induced by adriamycin in bladder carcinoma BIU87 cells
-
Zhang GJ, Zhang Z (2013). Effect of Bcl-2 on apoptosis and transcription factor NF-kappaB activation induced by adriamycin in bladder carcinoma BIU87 cells. Asian Pac J Cancer Prev, 14, 2387-91.
-
(2013)
Asian Pac J Cancer Prev
, vol.14
, pp. 2387-2391
-
-
Zhang, G.J.1
Zhang, Z.2
-
82
-
-
33847107236
-
DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer
-
Zheng Z, Chen T, Li X, et al (2007). DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer. N Engl J Med, 356, 800-8.
-
(2007)
N Engl J Med
, vol.356
, pp. 800-808
-
-
Zheng, Z.1
Chen, T.2
Li, X.3
-
83
-
-
61449178847
-
Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer
-
Zhu ZH, Sun BY, Ma Y, et al (2009). Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer. J Clin Oncol, 27, 1091-9.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1091-1099
-
-
Zhu, Z.H.1
Sun, B.Y.2
Ma, Y.3
|